158 related articles for article (PubMed ID: 32893078)
1. Dominant SCN2A mutation with variable phenotype in two generations.
Passi GR; Mohammad SS
Brain Dev; 2021 Jan; 43(1):166-169. PubMed ID: 32893078
[TBL] [Abstract][Full Text] [Related]
2. Understanding the schizophrenia phenotype in the first patient with the full SCN2A phenotypic spectrum.
Suddaby JS; Silver J; So J
Psychiatr Genet; 2019 Jun; 29(3):91-94. PubMed ID: 30741786
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia.
Schwarz N; Hahn A; Bast T; Müller S; Löffler H; Maljevic S; Gaily E; Prehl I; Biskup S; Joensuu T; Lehesjoki AE; Neubauer BA; Lerche H; Hedrich UBS
J Neurol; 2016 Feb; 263(2):334-343. PubMed ID: 26645390
[TBL] [Abstract][Full Text] [Related]
4. Progress in Understanding and Treating SCN2A-Mediated Disorders.
Sanders SJ; Campbell AJ; Cottrell JR; Moller RS; Wagner FF; Auldridge AL; Bernier RA; Catterall WA; Chung WK; Empfield JR; George AL; Hipp JF; Khwaja O; Kiskinis E; Lal D; Malhotra D; Millichap JJ; Otis TS; Petrou S; Pitt G; Schust LF; Taylor CM; Tjernagel J; Spiro JE; Bender KJ
Trends Neurosci; 2018 Jul; 41(7):442-456. PubMed ID: 29691040
[TBL] [Abstract][Full Text] [Related]
5. The phenotypic spectrum of SCN2A-related epilepsy.
Reynolds C; King MD; Gorman KM
Eur J Paediatr Neurol; 2020 Jan; 24():117-122. PubMed ID: 31924505
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic spectrum of SCN2A-associated episodic ataxia.
Schwarz N; Bast T; Gaily E; Golla G; Gorman KM; Griffiths LR; Hahn A; Hukin J; King M; Korff C; Miranda MJ; Møller RS; Neubauer B; Smith RA; Smol T; Striano P; Stroud B; Vaccarezza M; Kluger G; Lerche H; Fazeli W
Eur J Paediatr Neurol; 2019 May; 23(3):438-447. PubMed ID: 30928199
[TBL] [Abstract][Full Text] [Related]
7. Episodic ataxia associated with a de novo SCN2A mutation.
Leach EL; van Karnebeek CD; Townsend KN; Tarailo-Graovac M; Hukin J; Gibson WT
Eur J Paediatr Neurol; 2016 Sep; 20(5):772-6. PubMed ID: 27328862
[TBL] [Abstract][Full Text] [Related]
8. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
[TBL] [Abstract][Full Text] [Related]
9. Dominant SCN2A Mutation Causes Familial Episodic Ataxia and Impairment of Speech Development.
Fazeli W; Becker K; Herkenrath P; Düchting C; Körber F; Landgraf P; Nürnberg P; Altmüller J; Thiele H; Koy A; Liebau MC; Simon T; Dötsch J; Cirak S
Neuropediatrics; 2018 Dec; 49(6):379-384. PubMed ID: 30165711
[TBL] [Abstract][Full Text] [Related]
10. Whole-Exome Sequencing Implicates
Maksemous N; Smith RA; Sutherland HG; Sampaio H; Griffiths LR
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314295
[TBL] [Abstract][Full Text] [Related]
11. Commonalities and distinctions between two neurodevelopmental disorder subtypes associated with SCN2A and SCN8A variants and literature review.
Mangano GD; Fontana A; Antona V; Salpietro V; Mangano GR; Giuffrè M; Nardello R
Mol Genet Genomic Med; 2022 May; 10(5):e1911. PubMed ID: 35348308
[TBL] [Abstract][Full Text] [Related]
12.
Yang XR; Ginjupalli VKM; Theriault O; Poulin H; Appendino JP; Au PYB; Chahine M
J Neurophysiol; 2022 May; 127(5):1388-1397. PubMed ID: 35417276
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond.
Wolff M; Brunklaus A; Zuberi SM
Epilepsia; 2019 Dec; 60 Suppl 3():S59-S67. PubMed ID: 31904126
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and genetic spectrum of SCN2A gene associated epilepsy and episodic ataxia].
Guan J; Du KX; Dong Y; Li L; Song PP; Gong H; Zhang XL; Jia TM
Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):51-55. PubMed ID: 34986624
[No Abstract] [Full Text] [Related]
15. The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features.
Liang JS; Lin LJ; Yang MT; Wang JS; Lu JF
Brain Dev; 2017 Nov; 39(10):877-881. PubMed ID: 28709814
[TBL] [Abstract][Full Text] [Related]
16. SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain.
Liao Y; Anttonen AK; Liukkonen E; Gaily E; Maljevic S; Schubert S; Bellan-Koch A; Petrou S; Ahonen VE; Lerche H; Lehesjoki AE
Neurology; 2010 Oct; 75(16):1454-8. PubMed ID: 20956790
[TBL] [Abstract][Full Text] [Related]
17. De novo SCN2A splice site mutation in a boy with Autism spectrum disorder.
Tavassoli T; Kolevzon A; Wang AT; Curchack-Lichtin J; Halpern D; Schwartz L; Soffes S; Bush L; Grodberg D; Cai G; Buxbaum JD
BMC Med Genet; 2014 Mar; 15():35. PubMed ID: 24650168
[TBL] [Abstract][Full Text] [Related]
18. Further delineation of phenotypic spectrum of SCN2A-related disorder.
Richardson R; Baralle D; Bennett C; Briggs T; Bijlsma EK; Clayton-Smith J; Constantinou P; Foulds N; Jarvis J; Jewell R; Johnson DS; McEntagart M; Parker MJ; Radley JA; Robertson L; Ruivenkamp C; Rutten JW; Tellez J; Turnpenny PD; Wilson V; Wright M; Balasubramanian M
Am J Med Genet A; 2022 Mar; 188(3):867-877. PubMed ID: 34894057
[TBL] [Abstract][Full Text] [Related]
19. Confirming an expanded spectrum of SCN2A mutations: a case series.
Matalon D; Goldberg E; Medne L; Marsh ED
Epileptic Disord; 2014 Mar; 16(1):13-8. PubMed ID: 24659627
[TBL] [Abstract][Full Text] [Related]
20. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
